journal article·2023-09

Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis

Xuan Meng, Lin Wang, Ning Zhao, Delong Zhao, Yongli Shen, Yuan Yao, Wenjie Jing, Shuli Man, Yujie Dai, Yanjun Zhao

Acta Biomaterialia· Volume 167
Publisher page

Abstract

The solid tumors are characterized with oxidative stress and metabolic reprogramming, which has been independently used for targeted tumor monotherapy. However, the potential of targeting metabolism-redox circuit in tumor therapy has long been neglected. Herein, we report a hybrid nanocarrier for concurrent targeting of glycolysis and redox balance in the current work. The nanocarriers are made of pH- and ATP-responsive zeolitic imidazolate framework (ZIF-8) as the porous core that was further coated with poloxamer 407 as the steric stabilizer. Two active cargos, glucose oxidase (GOx) and 3-bromopyruvate (3-BrPA) were co-loaded in the core of nanocarrier. GOx is well-known for its ability of producing hydrogen peroxide at the expense of glucose and oxygen. 3-BrPA can reduce oxygen and glucose consumption through glycolysis, which sensitized cancer cells to GOx-induced apoptosis. At the cellular level, the hybrid nanocarrier significantly impaired the redox balance in the liver hepatocellular carcinoma cell line (HepG2), as evidenced by the depletion of glutathione and boost of reactive oxygen species. The potency of hybrid nanocarrier in terms of suppressing HepG2 cell energy metabolism was proven by the exhaustion of ATP. As a consequence, cell viability was greatly reduced. The in vivo efficacy of hybrid nanocarriers was demonstrated in HepG2 tumor-bearing mice. The current work presents an approach of targeting metabolism-redox circuit for tumor treatment, which may enrich the available anti-tumor strategies. STATEMENT OF SIGNIFICANCE: Metabolic alterations and elevated reactive oxygen species (ROS) are two characteristics of cancer. The metabolic patterns of cancer cells are elaborately reprogrammed to enable the rapid propagation of cancer cells. However, the potential of targeting the metabolism-redox circuit in anti-tumor therapy has long been neglected. As a proof-of-concept, we report an engineered stimuli-responsive nanomedicine that can eradicate cancer cells via cooperative glycolysis inhibition and redox impairment. The current work presents an approach of targeting the metabolism-redox circuit for tumor treatment, which may enrich the available anti-tumor strategies.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (45)

Show source-provided references
1. Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug10.1007/s10863-012-9422-7 ↗
2. Understanding the Warburg effect: the metabolic requirements of cell proliferation10.1126/science.1160809 ↗
3. A nanounit strategy disrupts energy metabolism and alleviates immunosuppression for cancer therapy10.1021/acs.nanolett.2c02475 ↗
4. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression10.1080/09553002.2019.1589653 ↗
5. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy10.1021/acsnano.7b02533 ↗
6. Advances in nanomedicine for cancer starvation therapy10.7150/thno.38261 ↗
7. Tumor-derived exosomes co-delivering aggregation-induced emission luminogens and proton pump inhibitors for tumor glutamine starvation therapy and enhanced type-I photodynamic therapy10.1016/j.biomaterials.2022.121462 ↗
8. Tumor-specific chemotherapy by nanomedicine-enabled differential stress sensitization10.1002/anie.202002306 ↗
9. Augmenting tumor-starvation therapy by cancer cell autophagy inhibition10.1002/advs.201902847 ↗
10. The sustainability of energy conversion inhibition for tumor ferroptosis therapy and chemotherapy10.1002/smll.202102695 ↗
11. Biodegradable calcium phosphate nanotheranostics with tumor-specific activatable cascade catalytic reactions-augmented photodynamic therapy10.1002/adfm.202009848 ↗
12. Phosphate-degradable nanoparticles based on metal-organic frameworks for chemo-starvation-chemodynamic synergistic antitumor therapy10.1021/acsami.1c10816 ↗
13. Double-lock nanomedicines enable tumor-microenvironment-responsive selective antitumor therapy10.1002/adfm.202009157 ↗
14. Targeting metabolic-redox circuits for cancer therapy10.1016/j.tibs.2019.01.001 ↗
15. Modulation of oxidative stress as an anticancer strategy10.1038/nrd4002 ↗
16. ROS homeostasis and metabolism: a dangerous liason in cancer cells10.1038/cddis.2016.105 ↗
17. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway10.1186/s12943-017-0648-1 ↗
18. Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH10.1126/science.aaa5004 ↗
19. Free radicals and antioxidants in normal physiological functions and human disease10.1016/j.biocel.2006.07.001 ↗
20. A "valve-closing" starvation strategy for amplification of tumor-specific chemotherapy10.1002/advs.202104671 ↗
21. Chemical modulation of glucose metabolism with a fluorinated CaCO3 nanoregulator can potentiate radiotherapy by programming antitumor immunity10.1021/acsnano.2c02688 ↗
22. Zeolitic imidazolate framework platform for combinational starvation therapy and oxygen self-sufficient photodynamic therapy against a hypoxia tumor10.1021/acsabm.1c00174 ↗
23. Biomineralized two-enzyme nanoparticles regulated tumor glycometabolism inducing tumor cell pyroptosis and robust anti-tumor immunotherapy10.1002/adma.202206851 ↗
24. Targeting cancer cells using 3-bromopyruvate for selective cancer treatment10.4103/1658-631X.194253 ↗
25. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
26. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
27. Cancer nanomedicine: progress, challenges and opportunities
28. Multifunctional zeolitic imidazolate framework-8 for real-time monitoring ATP fluctuation in mitochondria during photodynamic therapy10.1039/D0NR02149K ↗
29. Nanoscale ATP-responsive zeolitic imidazole framework-90 as a general platform for cytosolic protein delivery and genome editing10.1021/jacs.8b11996 ↗
30. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase10.1371/journal.pone.0002599 ↗
31. Sugar-free approaches to cancer cell killing10.1038/onc.2010.466 ↗
32. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation10.1016/j.tox.2020.152413 ↗
33. Delphinidin increases the sensitivity of ovarian cancer cell lines to 3-bromopyruvate10.3390/ijms22020709 ↗
34. 3-Bromopyruvic acid inhibits tricarboxylic acid cycle and glutaminolysis in HepG2 Cells
35. Energy-free singlet oxygen-based chemodynamic therapy for selective tumor treatment without dark toxicity10.1002/adhm.201900366 ↗
36. Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation10.1021/nn406590q ↗
37. Triggered all-active metal organic framework: ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy10.1021/acs.nanolett.9b02904 ↗
38. Advanced cancer starvation therapy by simultaneous deprivation of lactate and glucose using a MOF nanoplatform10.1002/advs.202101467 ↗
39. Imidazole- and imidazolium-containing polymers for biology and material science applications10.1016/j.polymer.2010.02.006 ↗
40. Discovery of quantitative electronic structure-OER activity relationship in metal-organic framework electrocatalysts using an integrated theoretical-experimental approach10.1002/adfm.202102066 ↗
41. Ligand-engineered metal-organic frameworks for electrochemical reduction of carbon dioxide to carbon monoxide10.1021/acscatal.1c01506 ↗
42. A Cu(II)-ATP complex efficiently catalyses enantioselective Diels-Alder reactions10.1038/s41467-020-18554-x ↗
43. Ratiometric co-delivery of multiple chemodrugs in a single nanocarrier10.1016/j.ejps.2017.06.030 ↗
44. Reaction rate of pyruvate and hydrogen peroxide: assessing antioxidant capacity of pyruvate under biological conditions10.1038/s41598-019-55951-9 ↗
45. Mitochondrial dysfunction and antioxidation syshomeostasis-enhanced tumor starvation synergistic chemotherapy achieved using a metal-organic framework-based nano-enzyme reactor10.1021/acsami.1c18654 ↗